There is now strong evidence that the risk of developing clinical coronary heart disease (CHD) 
Introduction
Of the 4 major lipoprotein classes of plasma (Table 1) , the high density, or alpha, lipoproteins (HDL) had until recently received the least attention. Composed mostly of specific proteins and phospholipid, HDL makes only a minor contribution to the plasma total cholesterol (usually <25%) and triglyceride (usually < 10%) concentrations, and is also more difficult to isolate and quantify than the other classes. Although case-control studies in the 1950s had repeatedly documented low mean HDL cholesterol concentrations in coronary heart disease (CHD) victims, the 'infiltration theory' of atherogenesis, based largely on animal experiments, had polarized thought to such an extent that the phenomenon was overlooked, or disregarded as being of no pathological significance. HDL cholesterol, CHD and atherosclerosis Miller and Miller (1975) (Glomset, 1970) .
During the past 5 years a body of data has (Rhoads, Gulbrandsen and Kagan, 1976) and the Cooperative Lipoprotein Phenotyping Study and by 3 prospective studies: the Tromso Heart Study in Norway (Miller et al., 1977) (Hammett et al., 1979) . A 10-year follow-up study by Gofman and (Robinson, Williams and Day, 1979) who appear to possess a low mean HDL cholesterol level, but who nevertheless also have a low CHD incidence. Although susceptiblity to CHD appears to be increased in familial HDL deficiency (Tangier disease), it is probably not increased to the extent that would be anticipated on the basis of the epidemiological relationships (Assmann, 1978) .
Although such apparent inconsistencies might merely reflect a coincidental absence of other risk factors (most of the above situations are, for example, associated also with low plasma LDL (low density lipoprotein) cholesterol concentrations), they raise the possibility that the HDL-CHD relationship is not a simple one.
Perhaps the most important consideration in the present context, however, is the present lack of evidence for a causal relationship between HDL metabolism and atherogenesis. The original working hypothesis (Miller and Miller, 1975) , that the plasma HDL cholesterol concentration is a reflection of the efficiency of cholesterol transport mechanisms from peripheral tissues by virtue of a role of HDL or its precursors in that process, has already been mentioned. Although supported by more recent studies, this concept remains unproved. So also does the suggestion that HDL may retard the uptake of LDL by arterial smooth muscle cells (Carew et al., 1976) . Consistent with both concepts is the evidence that the rate of accumulation of tissue cholesterol varies inversely with the plasma HDL cholesterol concentration (Miller, Nestel and Clifton-Bligh, 1976; Nestel and Miller, 1980 (Williams, Robinson and Bailey, 1979) , no clear picture has yet emerged of the effects of weight reduction on HDL cholesterol. In crosssectional data HDL cholesterol also decreases with increasing cigarette consumption Garrison et al., 1978) (Hulley, Cohen and Widdowson, 1977; F0rde et al., 1978) . Twin studies have indicated that these are unlikely to be genetic (Feinleib et al., 1977) . Some of them are certain to be dietary, and there is a particular paucity of information in this area. What little information is available suggests that dietary cholesterol increases HDL concentration slightly (Applebaum-Bowden et al., 1979; Mistry et al., 1976) 
